E. Santacana

PREDICTORS OF INFLIXIMAB TROUGH CONCENTRATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS USING A REPEATED MEASURES DESIGN.

H. Colom, F. Rodríguez-Moranta, J. Guardiola, 2020, Therapeutic drug monitoring.

External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease

H. Colom, J. Guardiola, A. Padullés, 2017, Therapeutic drug monitoring.

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

M. Gasa, A. Ariza-Solé, J. Sabater, 2020, International Journal of Infectious Diseases.